Brighter's Subsidiary Nectarine Health Expands User Friendly Trial in U.S.

Brighter AB (publ) announced today that the company’s subsidiary Nectarine Health has begun extending its friendly user trials in the U.S. which was previously announced on 12 February 2021 (press release). Nectarine Health has initiated a campaign to bring on board 40 more friendly users through its website and social media channels. The aim of the friendly user extension is to receive further feedback on the latest version of Nectarine Health™ at Home and to receive additional data points on "activities of daily living" (ADL).

Friendly users will be able to purchase Nectarine Health™ at Home at a discount if they wish to continue with the service. As such, the company is publishing price points for its solution. These are not final and subject to change:

Monthly: $399.99 upfront fee + $39.99 per month

Yearly: $399.99 upfront fee + $399 per year

"This is another essential step towards our commercialization plan in the U.S.", says Matthias Tietze, CEO of Nectarine Health. "It is our long-term vision to help provide an affordable solution that supports ageing at home."

For more information, please contact:

Investor Relations
ir@brighter.se

Certified Adviser

Brighter's Certified Adviser is Eminova Fondkommission AB, +46 [0)8 - 684 211 10, adviser@eminova.se, www.eminova.se.

About Nectarine Health

Nectarine Health™ at Home is an AI-based well-being technology that is built for life-loving independence. It aims to empower seniors to live independently at home for longer, promoting feelings of safety and security, knowing that help is always at hand. Nectarine Health is an international company with a team of 40 and headquarters in Gamla Stan, Stockholm, Sweden. We believe that better and more intelligent tools can help society improve and maintain the quality of care for its ageing global population.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. https://brighter.se/